HuGE Literature Finder
Records
1
-
3
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. European archives of psychiatry and clinical neuroscience 2012 Oct . Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine. Pharmacogenomics 2010 Nov 11 (11): 1535-43. Lin Keh-Ming, Tsou Hsiao-Hui, Tsai I-Ju, Hsiao Mei-Chun, Hsiao Chin-Fu, Liu Chia-Yih, Shen Winston W, Tang Hwa-Sheng, Fang Chun-Kai, Wu Chi-Shin, Lu Shao-Chun, Kuo Hsiang-Wei, Liu Shu Chih, Chan Hsiu-Wen, Hsu Ya-Ting, Tian Jia-Ni, Liu Yu- |
CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population. Clinical neuropharmacology 0 42 (2): 32-36. Zhu Yuhao, Zhang Naixing, Ren Decheng, Bi Yan, Xu Fei, Niu Weibo, Sun Qianqian, Guo Zhenming, Yuan Ruixue, Yuan Fan, Wu Xi, Cao Yanfei, Yang Fengping, Wang Lu, Du Li, Li Weidong, Xu Yifeng, Li Xingwang, Zhu Liping, He Lin, Shi Lei, He Guang, Yu T |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: